Combined Phenotype of 4 Markers Improves Prognostic Value of Patients With Colon Cancer

Key laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University Cancer Hospital & Institute, Haidian District, Beijing, China.
The American Journal of the Medical Sciences (Impact Factor: 1.52). 01/2012; 343(4):295-302. DOI: 10.1097/MAJ.0b013e31822cb4cd
Source: PubMed

ABSTRACT Combination of multiple biomarkers representing distinct aspects of tumor biology will have a better prognostic value. This study was to identify prognostic subgroups of colon adenocarcinoma by combined analysis of synuclein-gamma (SNCG), a human homologue of piwi (Hiwi), phosphatase of regenerating liver-3 (PRL-3), arrest-defective protein 1, homolog A (ARD1) and clinicopathologic features in 225 colon adenocarcinoma specimens.
Immunohistochemistry for 4 tumor markers was performed in whole tissue sections from 225 colon adenocarcinoma patients with complete clinicopathologic data and up to 10-year follow-up. The immunohistochemical expression patterns were examined individually and in multimarker combinations. Univariate and multivariate analyses were performed to identify independent predictive markers of poor outcome.
With the tumor marker positive rate [32.0% (62/225) for SNCG; 76.9% (173/225) for combined SNCG/Hiwi/PRL-3/ARD1] and the detecting accuracy [61.9% (252/407) for SNCG; 82.6% (336/407) for combined SNCG/Hiwi/PRL-3/ARD1] increasing, incremental value of combined SNCG/Hiwi/PRL-3/ARD1 (P < 0.001; hazard ratios (HR), 3.2) to poor outcome was found. Stratified by lymph node, Hiwi alone (P = 0.004; HR, 3.2) led to poor outcome in patients without lymph node metastasis (LN-), and SNCG (P < 0.001; HR, 2.5) had independently poor prognostic value for patients with lymph node metastasis (LN+).
Multimarker phenotypes improved tumor positive rate, detecting accuracy and prognostic value. In addition, a subgroup of more aggressive tumors can be identified by evaluating Hiwi level in LN- cancer, and SNCG level in LN+ cancer.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The HIWI gene is one of the members of the PIWI gene family that is important for stem cell self‑renewal and expressed highly in certain human tumors. Some studies have demonstrated that HIWI plays a key role in the development of tumors in cervical, colon and liver cancer. Previous studies have demonstrated that HIWI is associated with prognosis of patients with glioma. However, there is no report on the analysis of HIWI in the biological characteristics of glioma cells. The aim of the study was to investigate whether HIWI plays an important role in the progress of glioma. Silencing HIWI inhibited cell proliferation by promoting apoptosis and increased cell cycle arrest. The expression of proteins related to apoptosis and the cell cycle, including p21, cyclin D1, Bcl‑2, and Bax was significantly altered. Moreover, knockdown of HIWI inhibited the migration and invasion of glioma cells by reducing the expression of MMP‑2 and MMP‑9. Furthermore, we found that reduction of HIWI inhibited tumor growth in vivo. These findings suggest that HIWI is an oncogene involved in the progression of glioma.
    International Journal of Oncology 09/2014; 45(6). DOI:10.3892/ijo.2014.2673 · 2.77 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Hiwi, also named PiwiL1, is a human homologue of the Piwi family which is associated with stem cells and is overexpressed in several types of cancers. In the present study, we aimed to investigate the role of Hiwi in cervical carcinogenesis. Immunochemical analysis showed a significantly higher frequency of Hiwi staining in high-grade squamous intraepithelial lesions (HSILs) and cervical cancer tissues when comparing with the frequency in normal cervices. Particularly, Hiwi staining was restricted to basal cells of the normal cervix and was associated with the progression of cervical cancer and chemotherapy resistance. We further found that ectopic Hiwi increased the chemical resistance in SiHa cells, and silencing of Hiwi in HeLa cells decreased the cell viability. In addition, as a cancer stem cell marker, Hiwi promoted the tumorsphere formation in vitro and tumorigenicity in vivo and elevated the expression of several stem cell self-renewal-associated transcription factors, in spite of inhibited the proliferation. These results suggest that Hiwi may participate in the carcinogenesis of cervical cancer and may be a potential therapeutic target molecule for cervical cancers.
    Oncology Reports 08/2014; 32(5). DOI:10.3892/or.2014.3401 · 2.19 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Synuclein-γ (SNCG) is a chaperone protein and exists mainly in cytoplasm. SNCG confers chemo-resistance and is a potential unfavorable biomarker for multiple types of cancer. Our previous work demonstrated that SNCG could be detected in the serum of cancer patients and the medium of cultured cancer cells, but the mechanism of SNCG secretion and its biological roles are unknown. Here we showed that SNCG levels in the culture medium were positively correlated with cancer cell densities and concentrations of fetal calf serum added. SNCG secretion was unaffected by Brefeldin A (BFA), an inhibitor of the classical protein transport pathway, but was antagonized by exosome inhibitor, lysosome inhibitor, ABC transporter inhibitor, inhibitor of phosphatidylinositide 3-kinase (PI3K), and knockdown of Rab27a. Ultracentrifugation fractionation revealed intracellular SNCG had both free and vesicle-associated forms, but the extracellular SNCG was mainly free. Results of reciprocal co-immunoprecipitation experiments showed the interaction between SNCG and Flotillin-2, a marker of exosome and lipid raft. Moreover, we demonstrated that SNCG protein, both secreted from tumor cells and exogenously added, markedly promoted cancer cell migration and invasion, but had no effect on non-cancerous cells. These findings suggest that SNCG is actively secreted by cancer cells via unconventional secretion pathway and contributes to aggressive phenotypes of cancer cells. This article is protected by copyright. All rights reserved.
    FEBS Journal 09/2014; 281(22). DOI:10.1111/febs.13055 · 3.99 Impact Factor